171 related articles for article (PubMed ID: 12057101)
1. Intracavitary therapies for mesothelioma.
Verschraegen CF
Curr Treat Options Oncol; 2001 Oct; 2(5):385-94. PubMed ID: 12057101
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermia: has its time come?
Smythe WR; Mansfield PF
Ann Surg Oncol; 2003 Apr; 10(3):210-2. PubMed ID: 12679303
[No Abstract] [Full Text] [Related]
3. Intraperitoneal chemotherapy for malignant peritoneal mesothelioma.
Vlasveld LT; Gallee MP; Rodenhuis S; Taal BG
Eur J Cancer; 1991; 27(6):732-4. PubMed ID: 1829913
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Anand A; Anand A; Anand N
Cancer; 1996 May; 77(9):1959-60. PubMed ID: 8646700
[No Abstract] [Full Text] [Related]
5. Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma.
Colaut F; Toniolo L; Vicario G; Scapinello A; Visentin C; Manente P; Sartori CA
Chir Ital; 2004; 56(6):781-6. PubMed ID: 15771030
[TBL] [Abstract][Full Text] [Related]
6. Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma.
Hesdorffer ME; Chabot JA; Keohan ML; Fountain K; Talbot S; Gabay M; Valentin C; Lee SM; Taub RN
Am J Clin Oncol; 2008 Feb; 31(1):49-54. PubMed ID: 18376228
[TBL] [Abstract][Full Text] [Related]
7. Results of systemic pemetrexed-based combination chemotherapy versus cytoreductive surgery and hyperthermic intraperitoneal cisplatin and doxorubicin on survival in malignant peritoneal mesothelioma.
Saxena A; Chua TC
Lung Cancer; 2009 Nov; 66(2):269-70. PubMed ID: 19733416
[No Abstract] [Full Text] [Related]
8. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
9. Malignant pleural and peritoneal mesothelioma: incidental diagnosis and excellent treatment results.
Miliauskas S; Zemaitis M; Pranys D
J Thorac Oncol; 2009 Mar; 4(3):435-6. PubMed ID: 19247093
[No Abstract] [Full Text] [Related]
10. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
de Bree E; van Ruth S; Baas P; Rutgers EJ; van Zandwijk N; Witkamp AJ; Zoetmulder FA
Chest; 2002 Feb; 121(2):480-7. PubMed ID: 11834661
[TBL] [Abstract][Full Text] [Related]
11. Emerging drugs for mesothelioma.
Scagliotti GV; Selvaggi G
Expert Opin Emerg Drugs; 2007 Mar; 12(1):127-37. PubMed ID: 17355218
[TBL] [Abstract][Full Text] [Related]
12. Local treatment of malignant pleural mesothelioma with intracavitary cytosine-arabinoside and cisplatin.
Aitini E; Pasquini E; Cavazzini G; Fattori PP; Smerieri F
Ann Oncol; 1992 Nov; 3(9):771-2. PubMed ID: 1450068
[No Abstract] [Full Text] [Related]
13. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025
[TBL] [Abstract][Full Text] [Related]
14. Complete response and long-term survival in malignant pleural mesothelioma: case report.
Takanen S; Resuli B; Graziano V; Parisi A; Lisi R; Raffetto N; Tombolini V
Anticancer Res; 2012 Apr; 32(4):1485-7. PubMed ID: 22493390
[TBL] [Abstract][Full Text] [Related]
15. A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma.
Yamanaka T; Tanaka F; Hasegawa S; Okada M; Soejima T; Kamikonya N; Fukuoka K; Nakano T
Jpn J Clin Oncol; 2009 Mar; 39(3):186-8. PubMed ID: 19131427
[TBL] [Abstract][Full Text] [Related]
16. [Surgery for malignant pleural mesothelioma].
Giudicelli R
Rev Pneumol Clin; 2004 Apr; 60(2):68-72. PubMed ID: 15133442
[TBL] [Abstract][Full Text] [Related]
17. Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin/interferon alfa-2a.
Soulié P; Ruffié P; Trandafir L; Monnet I; Tardivon A; Terrier P; Cvitkovic E; Le Chevalier T; Armand JP
J Clin Oncol; 1996 Mar; 14(3):878-85. PubMed ID: 8622036
[TBL] [Abstract][Full Text] [Related]
18. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
Tilleman TR; Richards WG; Zellos L; Johnson BE; Jaklitsch MT; Mueller J; Yeap BY; Mujoomdar AA; Ducko CT; Bueno R; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):405-11. PubMed ID: 19619785
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma. An NCI Canada Clinical Trials Group Study.
Eisenhauer EA; Evans WK; Murray N; Kocha W; Wierzbicki R; Wilson K
Invest New Drugs; 1988 Dec; 6(4):327-9. PubMed ID: 3229945
[TBL] [Abstract][Full Text] [Related]
20. Five reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal mesotheliomia [corrected].
Sugarbaker PH
Ann Surg Oncol; 2010 Jun; 17(6):1710-2; author reply 1713-4. PubMed ID: 20354799
[No Abstract] [Full Text] [Related]
[Next] [New Search]
